These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35689381)

  • 1. MicroRNA-124-3p-enriched small extracellular vesicles as a therapeutic approach for Parkinson's disease.
    Esteves M; Abreu R; Fernandes H; Serra-Almeida C; Martins PAT; Barão M; Cristóvão AC; Saraiva C; Ferreira R; Ferreira L; Bernardino L
    Mol Ther; 2022 Oct; 30(10):3176-3192. PubMed ID: 35689381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal Administration of Extracellular Vesicles Derived from Human Teeth Stem Cells Improves Motor Symptoms and Normalizes Tyrosine Hydroxylase Expression in the Substantia Nigra and Striatum of the 6-Hydroxydopamine-Treated Rats.
    Narbute K; Piļipenko V; Pupure J; Dzirkale Z; Jonavičė U; Tunaitis V; Kriaučiūnaitė K; Jarmalavičiūtė A; Jansone B; Kluša V; Pivoriūnas A
    Stem Cells Transl Med; 2019 May; 8(5):490-499. PubMed ID: 30706999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Mechanism of SNHG8/Microrna-421-3p/Sorting Nexin 8 Axis on Dopaminergic Neurons in Substantia Nigra in a Mouse Model of Parkinson's Disease.
    Zhou S; Zhou X; Jiang Z; Ma J; Li Y; Qian Z; Li H
    Neurochem Res; 2023 Mar; 48(3):942-955. PubMed ID: 36401052
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
    Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
    Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease.
    Oiwa Y; Yoshimura R; Nakai K; Itakura T
    Brain Res; 2002 Aug; 947(2):271-83. PubMed ID: 12176170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular Zn
    Tamano H; Nishio R; Morioka H; Takeda A
    Mol Neurobiol; 2019 Jan; 56(1):435-443. PubMed ID: 29705946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
    Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
    Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn dopaminergic neurons are associated with the migration and differentiation of SVZ-derived neural progenitors in a 6-hydroxydopamin-injected mouse model.
    Xie MQ; Chen ZC; Zhang P; Huang HJ; Wang TT; Ding YQ; Qi SS; Zhang C; Chen SX; Zhou P; Shao CC; Liao M; Sun CY
    Neuroscience; 2017 Jun; 352():64-78. PubMed ID: 28385636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral administration of the Class-IIa HDAC inhibitor MC1568 partially protects against nigrostriatal neurodegeneration in the striatal 6-OHDA rat model of Parkinson's disease.
    Mazzocchi M; Goulding SR; Morales-Prieto N; Foley T; Collins LM; Sullivan AM; O'Keeffe GW
    Brain Behav Immun; 2022 May; 102():151-160. PubMed ID: 35217173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA H19 diminishes dopaminergic neuron loss by mediating microRNA-301b-3p in Parkinson's disease via the HPRT1-mediated Wnt/β-catenin signaling pathway.
    Jiang J; Piao X; Hu S; Gao J; Bao M
    Aging (Albany NY); 2020 May; 12(10):8820-8836. PubMed ID: 32434961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-hydroxydopamine-induced Parkinson's disease-like degeneration generates acute microgliosis and astrogliosis in the nigrostriatal system but no bioluminescence imaging-detectable alteration in adult neurogenesis.
    Fricke IB; Viel T; Worlitzer MM; Collmann FM; Vrachimis A; Faust A; Wachsmuth L; Faber C; Dollé F; Kuhlmann MT; Schäfers K; Hermann S; Schwamborn JC; Jacobs AH
    Eur J Neurosci; 2016 May; 43(10):1352-65. PubMed ID: 26950181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. mGluR5 Allosteric Modulation Promotes Neurorecovery in a 6-OHDA-Toxicant Model of Parkinson's Disease.
    Farmer K; Abd-Elrahman KS; Derksen A; Rowe EM; Thompson AM; Rudyk CA; Prowse NA; Dwyer Z; Bureau SC; Fortin T; Ferguson SSG; Hayley S
    Mol Neurobiol; 2020 Mar; 57(3):1418-1431. PubMed ID: 31754998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chondroitinase ABC reduces dopaminergic nigral cell death and striatal terminal loss in a 6-hydroxydopamine partial lesion mouse model of Parkinson's disease.
    Fletcher EJR; Moon LDF; Duty S
    BMC Neurosci; 2019 Dec; 20(1):61. PubMed ID: 31862005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-221 rescues the loss of dopaminergic neurons in a mouse model of Parkinson's disease.
    Yao Y; Zhao Z; Zhang F; Miao N; Wang N; Xu X; Yang C
    Brain Behav; 2023 Mar; 13(3):e2921. PubMed ID: 36795044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-124 loaded nanoparticles enhance brain repair in Parkinson's disease.
    Saraiva C; Paiva J; Santos T; Ferreira L; Bernardino L
    J Control Release; 2016 Aug; 235():291-305. PubMed ID: 27269730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
    Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P
    Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-124-3p Modulates Alpha-Synuclein Expression Levels in a Paraquat-Induced in vivo Model for Parkinson's Disease.
    Esteves M; Cristóvão AC; Vale A; Machado-Pereira M; Ferreira R; Bernardino L
    Neurochem Res; 2024 Jul; 49(7):1677-1686. PubMed ID: 38451434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of microRNA-375 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease by inhibiting SP1.
    Cai LJ; Tu L; Li T; Yang XL; Ren YP; Gu R; Zhang Q; Yao H; Qu X; Wang Q; Tian JY
    Aging (Albany NY); 2020 Jan; 12(1):672-689. PubMed ID: 31927536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-214-3p promotes the pathogenesis of Parkinson's disease by inhibiting autophagy.
    Dong H; Yan J; Huang P; Wang X; Zhang R; Zhang C; Wang W; Qian W; Zhou J; Zhao Y; Gao J; Zhang M; Ma X; Wang Z; Yi C; Zhang J; Chen W
    Biomed Pharmacother; 2024 Feb; 171():116123. PubMed ID: 38211424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal insulin protects against substantia nigra dopaminergic neuronal loss and alleviates motor deficits induced by 6-OHDA in rats.
    Pang Y; Lin S; Wright C; Shen J; Carter K; Bhatt A; Fan LW
    Neuroscience; 2016 Mar; 318():157-65. PubMed ID: 26777890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.